Novavax sees start of U.S. COVID-19 vaccine trial in coming weeks after second delay

Vaccine maker Novavax Inc said on Monday it has pushed back the start of a U.S.-based, late-stage trial for its experimental COVID-19 vaccine and now expects it to begin in the coming weeks instead of November.

Q&A: Where are we in the COVID-19 vaccine race?

Large global trials of several COVID-19 vaccine candidates involving tens of thousands of participants are well underway with some having gathered sufficient data to seek emergency use authorisation.

Moderna to seek U.S., EU emergency authorization Monday after COVID-19 vaccine 94.1% effective

Moderna Inc said it will apply for U.S. and European emergency authorization of its COVID-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns.

Factbox: Moderna's mRNA coronavirus vaccine

Moderna Inc became the second U.S company to release full results from a large study of its experimental vaccine, saying it was 94.1% effective against COVID-19.

Turkey expected to tighten weekend COVID-19 measures -sources

Turkey is expected to tighten its new weekend curfews in the face a record rise in coronavirus cases, according to two sources familiar with the matter.

Turkey's COVID curfew fails to contain surging second wave

(This November 29 story corrects spelling of doctor's name in penultimate paragraph to Celalettin, not Celallettin))

Russia begins mass trials of second coronavirus vaccine

Russia plans to begin mass trials of its second coronavirus vaccine, EpiVacCorona, on people aged over 18 on Monday, the RIA news agency cited the consumer health watchdog Rospotrebnadzor as saying.

Merkel slams state premiers over Christmas hotel opening plan: sources

Chancellor Angela Merkel railed against the plans of some regional governments to let hotels open for family visits over Christmas, warning it risked worsening the coronavirus surge sweeping Germany, participants in a party meeting said.

China halts operation at Korean chip plant after worker tests positive for coronavirus

A Chinese factory owned by South Korean semiconductor giant SK Hynix Inc halted operations on Sunday after a plant worker was found to have an asymptomatic infection of the novel coronavirus, the official news agency Xinhua reported.

Ukrainian volunteers step in to battle oxygen shortage in hospitals

Lesya Lytvynova's phone never stops ringing. With one hand she soothes her three-month-old baby, with the other she answers calls from relatives of coronavirus patients desperate to get an oxygen generator.

French health body says nursing homes should get COVID-19 vaccine first

France's top health advisory body said on Monday it had recommended COVID-19 vaccinations should target retirement homes residents and their staff first when doses reach the country.

Related Videos

L.A. County to impose new COVID-19 restrictions

Los Angeles County to ban most social gatherings

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS